BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22987267)

  • 21. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G; Pietrelli L; Gurwith M; Bowden R
    Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
    Falci DR; da Rosa FB; Pasqualotto AC
    Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.
    Arrieta AC; Shea K; Dhar V; Cleary JP; Kukreja S; Morris M; Vargas-Shiraishi OM; Ashouri N; Singh J
    Clin Ther; 2010 Feb; 32(2):265-71. PubMed ID: 20206784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*.
    Udy AA; Baptista JP; Lim NL; Joynt GM; Jarrett P; Wockner L; Boots RJ; Lipman J
    Crit Care Med; 2014 Mar; 42(3):520-7. PubMed ID: 24201175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates.
    Friedlich PS; Steinberg I; Fujitani A; deLemos RA
    Am J Perinatol; 1997 Aug; 14(7):377-83. PubMed ID: 9263555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal impairment and amphotericin B formulations in patients with invasive fungal infections.
    Saliba F; Dupont B
    Med Mycol; 2008 Mar; 46(2):97-112. PubMed ID: 18324488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
    BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA
    Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
    Yang H; Chaudhari P; Zhou ZY; Wu EQ; Patel C; Horn DL
    Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial.
    Slobbe L; Boersma E; Rijnders BJ
    Pulm Pharmacol Ther; 2008 Dec; 21(6):855-9. PubMed ID: 18951992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of liposomal amphotericin B in critically ill patients: a retrospective, multicenter, clinical study.
    Alvarez-Lerma F; Mariscal F; Quintana E; Rialp G; Diaz-Reganon J; Perez MJ; Alvarez-Sanchez B; Ausin Aoiz I;
    J Chemother; 2009 Jun; 21(3):330-7. PubMed ID: 19567355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study.
    Obata Y; Takazono T; Tashiro M; Ota Y; Wakamura T; Takahashi A; Sato K; Miyazaki T; Nishino T; Izumikawa K
    Clin Exp Nephrol; 2021 Mar; 25(3):279-287. PubMed ID: 33179180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.
    Alvarez-Lerma F; Allepuz-Palau A; Garcia MP; Angeles Leon M; Navarro A; Sanchez-Ruiz H; Iruretagoyena JR; Luque-Gomez P;
    J Chemother; 2008 Feb; 20(1):93-100. PubMed ID: 18343750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of amphotericin B lipid complex.
    Luke RG; Boyle JA
    Am J Kidney Dis; 1998 May; 31(5):780-5. PubMed ID: 9590187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
    Rothenbühler C; Held U; Manz MG; Schanz U; Gerber B
    Hematol Oncol; 2018 Apr; 36(2):471-480. PubMed ID: 29431860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.